Viewing Study NCT03503266



Ignite Creation Date: 2024-05-06 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 12:44 PM
Study NCT ID: NCT03503266
Status: COMPLETED
Last Update Posted: 2023-05-15
First Post: 2018-03-18

Brief Title: Mass Balance Study With MT-7117
Sponsor: Mitsubishi Tanabe Pharma America Inc
Organization: Mitsubishi Tanabe Pharma America Inc

Study Overview

Official Title: An Open-label Mass Balance Study to Investigate the Absorption Metabolism and Excretion of 14C-MT-7117 After a Single Oral Dose to Healthy Male Subjects
Status: COMPLETED
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MT-7117 MB
Brief Summary: This is a single-centre open-label mass balance study in healthy male subjects utilising a single oral dose of 14C MT 7117
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2017-004549-25 EUDRACT_NUMBER None None